Angelina Tjokrowidjaja

The development and validation of the Treatment of Autoimmune Bullous Disease Quality of Life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease

Angelina Tjokrowidjaja, Benjamin S. Daniel, John W. Frew et al. · British Journal of Dermatology · 2013 · 72 citations

Pre‐ and on‐treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non–small cell lung cancer

Angelina Tjokrowidjaja, Sarah J. Lord, Thomas John et al. · Cancer · 2022 · 38 citations · Full text

Metastatic breast cancer in young women: a population‐based cohort study to describe risk and prognosis

Angelina Tjokrowidjaja, Chee Khoon Lee, N. Houssami et al. · Internal Medicine Journal · 2014 · 28 citations

Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experience

L. Rhoda Molife, Salma Alam, David Olmos et al. · Annals of Oncology · 2012 · 28 citations · Full text

Oncology, Preclinical Drug Evaluation, Medicine +9

Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy

Angelina Tjokrowidjaja, Chee Khoon Lee, Michael Friedländer et al. · European Journal of Cancer · 2020 · 19 citations · Full text